148 related articles for article (PubMed ID: 25128016)
1. Recombinant activated factor VIIa to treat refractory lower gastrointestinal hemorrhage in a patient with recently implanted mechanical valve: a case report.
Omar AS; Sudarsanan S; Ewila H; Kindawi A
BMC Res Notes; 2014 Aug; 7():535. PubMed ID: 25128016
[TBL] [Abstract][Full Text] [Related]
2. [Successful management of massive gastrointestinal bleeding using recombinant factor VIIa in an elderly patient with respiratory and renal failure].
Liu M; Wang G; Ma Q; Ren J; Guo L; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1215-6. PubMed ID: 25176101
[TBL] [Abstract][Full Text] [Related]
3. [The use of recombinant activated factor VII in a patient with uncontrolled bleeding from the gastrointestinal tract].
Vitković R; Petrović I
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():246-8. PubMed ID: 19562877
[TBL] [Abstract][Full Text] [Related]
4. Successful control of massive coumarol-induced acute upper gastrointestinal bleeding and correction of prothrombin time by recombinant active factor VII (Eptacog-alpha, NovoSeven) in a patient with a prosthetic aortic valve and two malignancies (chronic lymphoid leukaemia and lung cancer).
Udvardy M; Telek B; Mezey G; Batar P; Altorjay I
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):265-7. PubMed ID: 15060425
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa for treatment of gastrointestinal hemorrhage following rattlesnake envenomation.
Ruha AM; Curry SC
Wilderness Environ Med; 2009; 20(2):156-60. PubMed ID: 19594209
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa.
Girona E; Borrás-Blasco J; Conesa-García V; Navarro-Ruiz A; Solís J; García-Sepulcre MF; Oliver-García I
South Med J; 2007 Jun; 100(6):601-4. PubMed ID: 17591314
[TBL] [Abstract][Full Text] [Related]
7. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
8. [The use of recombinant activated factor VII in the treatment of gastrointestinal bleeding following acetylsalicylic acid therapy in a surgical patient].
Vucelić D; Sabljak P; Pesko P; Stojakov D; Keramatollah E; Nenadić B; Pejović D; Velicković D; Bjelović M
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():240-5. PubMed ID: 19562876
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
[TBL] [Abstract][Full Text] [Related]
10. Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding.
Vanek T; Straka Z; Hrabak J; Jares M; Brucek PJ; Votava J
Jpn Heart J; 2004 Sep; 45(5):855-60. PubMed ID: 15557726
[TBL] [Abstract][Full Text] [Related]
11. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
Hoffmann T; Assmann A; Dierksen A; Roussel E; Ullrich S; Lichtenberg A; Albert A; Sixt S
J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1564-1573.e8. PubMed ID: 29884487
[TBL] [Abstract][Full Text] [Related]
12. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
[TBL] [Abstract][Full Text] [Related]
13. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
14. [Our experience with recombinant activated factor VII (NovoSeven) in the high risk cardiosurgical patients with bleeding complication].
Miskolczi S; Vaszily M; Papp C; Péterffy A
Magy Seb; 2008; 61 Suppl():45-7. PubMed ID: 18504237
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
Ozcelik T; Ozkocaman V; Ozkalemkas F; Ali R; Altundal Y; Ozkan A; Tunali A
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):385-6. PubMed ID: 17473584
[No Abstract] [Full Text] [Related]
16. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VII following pediatric cardiac surgery.
Kylasam S; Mos K; Fijtin S; Webster B; Chard R; Egan J
J Intensive Care Med; 2009; 24(2):116-21. PubMed ID: 19188273
[TBL] [Abstract][Full Text] [Related]
18. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant factor VIIa in liver diseases.
Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
[TBL] [Abstract][Full Text] [Related]
20. Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.
Alsayegh F; Fakeir A; Alhumood S; Abdumalek K; Matar H; Samaul I; Nampoory N; Kabalawi H; Mousa SA
Clin Appl Thromb Hemost; 2009; 15(2):225-32. PubMed ID: 18160562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]